Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 3:356:j573.
doi: 10.1136/bmj.j573.

Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?

Affiliations

Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?

David J Fisher et al. BMJ. .

Abstract

Identifying which individuals benefit most from particular treatments or other interventions underpins so-called personalised or stratified medicine. However, single trials are typically underpowered for exploring whether participant characteristics, such as age or disease severity, determine an individual’s response to treatment. A meta-analysis of multiple trials, particularly one where individual participant data (IPD) are available, provides greater power to investigate interactions between participant characteristics (covariates) and treatment effects. We use a published IPD meta-analysis to illustrate three broad approaches used for testing such interactions. Based on another systematic review of recently published IPD meta-analyses, we also show that all three approaches can be applied to aggregate data as well as IPD. We also summarise which methods of analysing and presenting interactions are in current use, and describe their advantages and disadvantages. We recommend that testing for interactions using within-trials information alone (the deft approach) becomes standard practice, alongside graphical presentation that directly visualises this.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Provenance and peer review: Not commissioned; externally peer reviewed.

Figures

None
Fig 1 Use of a deluded approach to analyse and present interactions in meta-analysis , illustrating how the effect of an early supported hospital discharge (ESD) strategy might vary by whether a carer is present. Left panel presents the effect of ESD for each subgroup within each trial, but ordered by subgroup; and right panel presents just the meta-analysed effects for each subgroup. The difference between the effects in right panel gives a deluded analysis (mean difference of 2.23, 95% confidence interval −2.82 to 7.28, P=0.39). Sizing of squares are in proportion to the inverse of the variance of the estimates. Note that the subgroup meta-analysis estimates do not match exactly those originally reported, because we used a fixed effect model for simplicity, rather than the random-effects model used by the original authors. See also web appendix A3 for references of studies and appendix B2 for details of statistical reanalysis
None
Fig 2 Use of a deft approach to analyse and present interactions in meta-analysis , illustrating how the effect of an early supported hospital discharge (ESD) strategy might vary by whether a carer is present. The left panel again presents the effect of ESD for each subgroup within each trial, but now ordered by trial. The right panel shows the interactions between the effect of ESD and presence of a carer for each trial, along with a meta-analysis of the interaction estimates (mean difference –6.64, 95% confidence interval –13.65 to 0.71, P=0.77; heterogeneity of interaction estimates: Q=12.8, df=7, I2=45%). Daft and deluded interaction estimates are presented alongside for comparison. Squares are used to depict treatment effect and circles the interaction effects, with sizing in proportion to the inverse of the variance of the estimates
None
Fig 3 Scatter plot (logit scale) of P values from 31 deft reanalyses (see web appendix B) of treatment-covariate interactions against the corresponding daft reanalyses. Added lines are at P=0.1; arguably a suitable level of significance for an interaction test for which a trial was not powered
None
Fig 4 Bland-Altman plot showing level of agreement between treatment-covariate interactions from deluded and deft analyses. Thirty one interactions were reanalysed, but only 26 with outcomes measured by hazard ratios or odds ratios were plotted. The remaining five interactions, including our illustrative example, could not be included since their outcomes were measured by mean differences and were hence incompatible. Treatment-covariate interactions (measured on the log scale) might have a positive or a negative sign, but in this plot they have all been set to negative. Hence, differences in interaction effects below the zero line represent cases where a deluded analysis gives a result in the same direction as, but more extreme than, the equivalent deft analysis, and vice versa. Shaded area=Bland-Altman 95% limits of agreement14; solid line represents mean difference (bias); dashed lines are 95% confidence intervals around the mean difference

Comment in

References

    1. Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 2002;25:76-97. 10.1177/0163278702025001006 pmid:11868447. - DOI - PubMed
    1. Fisher DJ, Copas AJ, Tierney JF, Parmar MK. A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners. J Clin Epidemiol 2011;64:949-67. 10.1016/j.jclinepi.2010.11.016 pmid:21411280. - DOI - PubMed
    1. Riley RD, Lambert PC, Staessen JA, et al. Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med 2008;27:1870-93. 10.1002/sim.3165 pmid:18069721. - DOI - PubMed
    1. Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI. Anti-Lymphocyte Antibody Induction Therapy Study Group. Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med 2002;21:371-87. 10.1002/sim.1023 pmid:11813224. - DOI - PubMed
    1. Fearon P, Langhorne P. Early Supported Discharge Trialists. Services for reducing duration of hospital care for acute stroke patients. Cochrane Database Syst Rev 2012;9:CD000443.pmid:22972045. - PubMed